Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Subrata Sen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6884-6246; OpenAlex author ID A5039200530, A5059400765; NIH RePORTER profile ID 1968128. Sources: OpenAlex.

Their work

Papers
20 (first author 1, last author 4)
Trials
0
Grants
5
Labs led
1
Collaborators
87
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: none · 2014: 2 papers · 2015: 1 paper, 1 grant · 2016: 1 paper · 2017: 1 paper, 1 grant · 2018: none · 2019: 3 papers · 2020: none · 2021: 2 papers, 1 grant · 2022: none · 2023: 2 papers · 2024: 2 papers, 1 grant · 2025: none · 2026: 2 papers, 1 grant

Papers 20

  1. Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-29548-4↗
  2. Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study. Co-author DOI 10.1158/1078-0432.ccr-25-4061↗
  3. Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. Last author DOI 10.1016/j.gastha.2024.08.002↗
  4. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways. Co-author DOI 10.1093/carcin/bgae025↗
  5. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. Co-author DOI 10.1016/j.cca.2023.117567↗
  6. Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. Last author DOI 10.3390/ijms241914652↗
  7. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Last author DOI 10.1158/1940-6207.capr-20-0303↗
  8. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer. Co-author DOI 10.2196/26601↗
  9. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. Co-author DOI 10.1021/acs.jproteome.9b00132↗
  10. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progre… Co-author DOI 10.1158/1078-0432.ccr-18-1955↗
  11. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Co-author DOI 10.1158/1940-6207.capr-18-0201↗
  12. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djw341↗
  13. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Co-author DOI 10.18632/oncotarget.10924↗
  14. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Co-author DOI 10.1371/journal.pone.0139049↗
  15. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/mc.22023↗
  16. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. Last author DOI 10.7150/jca.10094↗
  17. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Co-author DOI 10.1002/mc.20808↗
  18. MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease. First author DOI 10.1007/s12038-011-9083-4↗
  19. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318219dafe↗
  20. A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Co-author DOI 10.1158/1940-6207.capr-10-0025↗

Grants 5

  1. Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer U01CA214263↗
  2. Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples U01CA252965↗
  3. Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC) U24CA224020↗
  4. Pancreatic Cyst Fluid miRNOME for Biomarkers of Pancreatic Cancer R21CA185962↗
  5. Biomarkers for the Early Detection of Pancreatic Cancer U01CA111302↗

Closest collaborators

The 25 strongest of 87 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ann McNeill Killary · 14 shared papers, 2 shared grants, 2011–2026 · strength 2.52
  2. Anirban Maitra · 8 shared papers, 1 shared grant, 2019–2026 · strength 1.58
  3. Eugene Jon Koay · 3 shared papers, 1 shared grant, 2019–2026 · strength 1.48
  4. Seetharaman Balasenthil · 7 shared papers, 2011–2026 · strength 0.93
  5. Suyu Liu · 5 shared papers, 2017–2026 · strength 0.75
  6. Hua Lu · 1 shared grant, 2024 · strength 0.72
  7. Tony Y. Hu · 1 shared grant, 2024 · strength 0.72
  8. Nagireddy Putluri · 4 shared papers, 2019–2026 · strength 0.68
  9. Randall E. Brand · 6 shared papers, 2015–2026 · strength 0.67
  10. Warapen Treekitkarnmongkol · 3 shared papers, 2023–2026 · strength 0.59
  11. Marsha L. Frazier · 8 shared papers, 1 shared grant, 2011–2017 · strength 0.50
  12. Ignacio Ivan Wistuba · 1 shared grant, 2021 · strength 0.44
  13. Ye Hu · 2 shared papers, 2024–2026 · strength 0.41
  14. Paul D. Lampe · 2 shared papers, 2024–2026 · strength 0.41
  15. Sudhir Srivastava · 3 shared papers, 2015–2026 · strength 0.32
  16. Michael Anthony Hollingsworth · 2 shared papers, 2015–2026 · strength 0.26
  17. Tsung-Hung Yao · 1 shared paper, 2026 · strength 0.24
  18. Suprateek Kundu · 1 shared paper, 2026 · strength 0.24
  19. Lynette M. Smith · 1 shared paper, 2026 · strength 0.23
  20. Masataka Hayashi · 1 shared paper, 2026 · strength 0.23
  21. Brianna M. Krusen · 1 shared paper, 2026 · strength 0.23
  22. Ann L. Oberg · 1 shared paper, 2026 · strength 0.23
  23. Michael Goggins · 1 shared paper, 2026 · strength 0.23
  24. Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.23
  25. Surinder K. Batra · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.